Jonathan Alicea

Investigators noted a higher prevalence of nuclear sclerotic cataracts in infected patients versus uninfected patients.

Although overall decrease in mortality was similar to the control group, sickle cell populations were still less likely to receive a kidney transplant.

The application, submitted by Merck, is based on data from 2 clinical trials evaluating patients with refractory or unexplained chronic cough.

In this first episode, Kim Smith-Whitley, MD, discusses the history, presentations, and research status of sickle cell disease.

Individuals with PH are often undiagnosed or misdiagnosed; therefore, the exact prevalence of the disorder is unclear.

Lisa Sarfaty, director of strategic planning for the National Organization for Rare Disorders, speaks on the role of the organization and the importance of the Rare Disease Day campaign.

Those who injected drugs and shared needles were more likely to have been screened for HCV if using mobile A-CHESS platform.

The approval is based on results from the ENVISION I Phase 3 study, which showed biologic use linked to clinical remission and maintenance in patients.

The reason for this decline has yet to be ascertained and thus warrants future research.

Children and adolescents with direct or indirect exposure to tobacco had higher odds of having elevated blood pressure.

Due to taboo or stigma, patients may not openly discuss their leg ulcers with their providers.

Up to 84% of younger patients note a positive experience with holistic therapeutic approaches to treating sickle cell-related pain.

An expert discusses findings that showed voxelotor (Oxbryta) improved leg ulcers in patients with sickle cell disease.

Compared with US census data, White individuals and women are overrepresented in clinical trials.

Noncompliance among younger patients and lack of education are issues that should continually be addressed by care teams.

According to a systematic review and meta-analysis of 8776 unique patients, 52.69% achieved repigmentation of >90%.

In a Q&A, 2 ophthalmologists provide an overview and offer some perspective on the risks and heritability associated with glaucoma.

The 3D-printed implant is patient specific and modeled after the anatomy of the individual.

Partnerships between primary care physicians and pulmonologists may improve vaccination rates for patients with COPD.

No approved treatment for leber hereditary optic neuropathy is currently available in the United States.

In a joint interview, 2 pediatric cardiologists discuss topics related to remote technologies and cardiological monitoring among pediatric populations.

Two pediatric cardiologists stress that recognizing symptoms of MIS-C is essential for primary care providers.

The company plans to submit the data to the FDA and EMA for consideration of the injectable bispecific antibody's regulatory approval for the treatment of both conditions.

A recent study reports that obese patients experienced high immunogenicity compared with those of normal weight.

The co-lead investigators discuss the upcoming first study to assess long-term outcomes on MIS-C patients.

This approval was granted to generic pharmaceutical company Akorn Operating Company, LLC.

Infants managed using real-time CGM spent longer time in the glucose concentration target range than those receiving standard of care.

Two pediatric cardiologists offer perspective on how to approach conversations about MIS-C with parents or guardians.

The approval is indicated for children ≥5 years old who inadequately respond to or are intolerant of anticholinergic medication.

Dongngan Truong, MD, and Jane Newburger, MD, discuss the current clinical understanding of MIS-C.